FDA reviewing safety of abortion drug mifepristone
The Food and Drug Administration (FDA) is moving ahead with a safety review of the abortion pill mifepristone, according to an administration official. The move marks a victory for anti-abortion groups that could pave the way for the Trump administration to restrict its use and how it can be distributed. The retrospective analysis of data…
Original Source
Read the full article at Thehill →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.